NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: C000000439

Registered date:01/07/2006

Phase 1/2 study of the combination of gemcitabine and nedaplation for treatment of previously untreated advanced squamous cell lung cancer

Basic Information

Recruitment status
Health condition(s) or Problem(s) studiedPreaviously untreated advanced advanced squamous cell lung cancer
Date of first enrollment2006/07/01
Target sample size32
Countries of recruitmentJapan
Study typeInterventional
Intervention(s)Combination chemotherapy with gemcitabine and nedaplation

Outcome(s)

Primary OutcomeRecommended dose Dose limmiting toxicity Response Rate
Secondary OutcomeOverall survival Time to progression Toxicity

Key inclusion & exclusion criteria

Age minimum20years-old
Age maximumNot applicable
GenderMale and Female
Include criteria
Exclude criteria1) Interstitial pneumonia or pulmonary fibrosis on chest X-P 2) peural or pericardial effusion requiring drainage 3) SVC syndrome 4) Symptomatic brain metastases 5) Active concominant malignancies 6) Uncontrolled diabetes mellitus or hypertension 7) Liver cirrhosis 8) Severe cardiovascular diseases 9) Pregnancy and lactation 10) Ccr<60ml/min 11) A history of serious drug allergy 12) Acute infection 13) Bleeding tendency 14) Unsuitable for entry to the study, decided by a medical oncologist

Related Information

Contact

public contact
Name Katsuhiro Masago
Address 54 Syogoin, Kawaramachi,Sakyo-Ku,Kyoto-City, Kyoto,Japan Japan
Telephone 075-751-3830
E-mail mio@kuhp.kyoto-u.ac.jp
Affiliation Kyoto unversity hospital Department of Respiratory Medicine
scientific contact
Name Tadashi Mio(Head),Katsuhiro Masago(Secretariat)
Address 54 Syogoin, Kawaramachi,Sakyo-Ku,Kyoto-City, Kyoto,Japan Japan
Telephone 075-751-3830
E-mail
Affiliation Kyoto University Hospital Department of Respiratory Medicine